Dr. Phillips’ clinical practice is dedicated to the operative and non-operative management
of urologic malignancies, with a particular focus on bladder and kidney malignancies. In
addition to her clinical work and involvement in ongoing clinical trials for the treatment of
urologic malignancies, Dr. Phillips is actively engaged
in basic science and translational research. She has
authored several peer-reviewed journal articles, scientific
abstracts and book chapters on the management of
urologic cancers, as well as the pathophysiology of
ischemia. Dr. Phillips has received awards from the
American Urological Association and the Engineering
and Urology Society for her scientific work
In the News:
Dr. Courtney Phillips discusses the risk factors of prostate cancer in The Daily News feature The Daily Check Up.
American Board of Urology
MD, New Jersey Medical School - Rutgers University
Bellevue Hospital Center
Bellevue Hospital Center
Columbia- Presbyterian Medical Center
Gin GE, Pereira JF, Weinberg AD, Mehrazin R, Lerner SM, Sfakianos JP, Phillips CK. Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers. Urologic oncology 2016 Feb; 34(2).
O'Malley RL, Godoy G, Phillips CK, Taneja SS. Is surveillance of small renal masses safe in the elderly?. BJU international 2010 Apr; 105(8).
Phillips CK, Hruby GW, Mirabile G, Motamedinia P, Lehman DS, Okhunov Z, Singh H, Schwartz M, Benson MC, Landman J. Erythropoietin-induced optimization of renal function after warm ischemia. Journal of endourology / Endourological Society 2009 Mar; 23(3).
Natalin RA, Phillips CK, Clayman RV, Landman J. Urologic laser types and instrumentation. Archivos españoles de urología 2008 Nov; 61(9).
Lehman DS, Phillips CK, Hruby GW, Lambert S, Landman J. An assessment of urologists' training and knowledge of energy-based surgical devices. BJU international 2008 Jul; 102(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Phillips did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.